AIMS: Hypertensive and other effects of excess glucocorticoids might be in part mediated by the suppression of endothelial nitric oxide synthase (eNOS) expression. We studied the transcriptional and biochemical mechanisms that mediate or modulate the suppression of eNOS expression by glucocorticoids. METHODS AND RESULTS: We found that a mere three-fold increase in the concentration of the natural glucocorticoid cortisol (from 30 to 100 nmol/L) significantly decreased the expression level of eNOS in human endothelial cells. Deletion analysis of the eNOS promoter indicated that the segment within -119 bp upstream from the transcription start site was significantly involved in the effect of cortisol. Site-directed mutagenesis and chromatin immunoprecipitation analyses demonstrated the presence of a suppressive glucocorticoid response element (GRE) at -111 to -105 bp. 11 beta-hydroxysteroid dehydrogenases (11 beta-HSD) catalyse the interconversion of active and inactive glucocorticoids. The suppression of 11 beta-HSD2 using small interfering RNA markedly exacerbated the inhibition of eNOS by cortisol. The suppression of 11 beta-HSD1 abolished the inhibition of eNOS expression by cortisol. CONCLUSION: We identified the first GRE in the eNOS promoter region and demonstrated that endogenous 11 beta-HSD1 and 11 beta-HSD2 play significant and distinct roles in modulating the effect of glucocorticoids on eNOS expression.
AIMS: Hypertensive and other effects of excess glucocorticoids might be in part mediated by the suppression of endothelial nitric oxide synthase (eNOS) expression. We studied the transcriptional and biochemical mechanisms that mediate or modulate the suppression of eNOS expression by glucocorticoids. METHODS AND RESULTS: We found that a mere three-fold increase in the concentration of the natural glucocorticoid cortisol (from 30 to 100 nmol/L) significantly decreased the expression level of eNOS in human endothelial cells. Deletion analysis of the eNOS promoter indicated that the segment within -119 bp upstream from the transcription start site was significantly involved in the effect of cortisol. Site-directed mutagenesis and chromatin immunoprecipitation analyses demonstrated the presence of a suppressive glucocorticoid response element (GRE) at -111 to -105 bp. 11 beta-hydroxysteroid dehydrogenases (11 beta-HSD) catalyse the interconversion of active and inactive glucocorticoids. The suppression of 11 beta-HSD2 using small interfering RNA markedly exacerbated the inhibition of eNOS by cortisol. The suppression of 11 beta-HSD1 abolished the inhibition of eNOS expression by cortisol. CONCLUSION: We identified the first GRE in the eNOS promoter region and demonstrated that endogenous 11 beta-HSD1 and 11 beta-HSD2 play significant and distinct roles in modulating the effect of glucocorticoids on eNOS expression.
Authors: Mingyu Liang; Baozhi Yuan; Elizabeth Rute; Andrew S Greene; Michael Olivier; Allen W Cowley Journal: Physiol Genomics Date: 2003-02-06 Impact factor: 3.107
Authors: T Wallerath; K Witte; S C Schäfer; P M Schwarz; W Prellwitz; P Wohlfart; H Kleinert; H A Lehr; B Lemmer; U Förstermann Journal: Proc Natl Acad Sci U S A Date: 1999-11-09 Impact factor: 11.205
Authors: Jeremy W Tomlinson; Elizabeth A Walker; Iwona J Bujalska; Nicole Draper; Gareth G Lavery; Mark S Cooper; Martin Hewison; Paul M Stewart Journal: Endocr Rev Date: 2004-10 Impact factor: 19.871
Authors: Clare Christy; Patrick W F Hadoke; Janice M Paterson; John J Mullins; Jonathan R Seckl; Brian R Walker Journal: Hypertension Date: 2003-08-18 Impact factor: 10.190
Authors: Brigitte Bocchi; Sabine Kenouch; Maxime Lamarre-Cliche; Martine Muffat-Joly; Michel Hubert Capron; Jean Fiet; Gilles Morineau; Michel Azizi; Jean Pierre Bonvalet; Nicolette Farman Journal: Hypertension Date: 2004-02-23 Impact factor: 10.190
Authors: Matthew A Bailey; Eilidh Craigie; Dawn E W Livingstone; Yuri V Kotelevtsev; Emad A S Al-Dujaili; Christopher J Kenyon; John J Mullins Journal: Hypertension Date: 2011-01-31 Impact factor: 10.190
Authors: Eugenia Mata-Greenwood; John M Stewart; Robin H Steinhorn; William J Pearce Journal: Arterioscler Thromb Vasc Biol Date: 2013-03-14 Impact factor: 8.311